ArticleJMIR medical informatics2025
Real-World Evaluation of AI-Driven Diabetic Retinopathy Screening in Public Health Settings: Validation and Implementation Study.
Article in JMIR medical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- When the algorithm passes the test but fails the patient.PLOS digital health · 2026Article
- Artificial intelligence in ophthalmology: From diagnostic accuracy to clinical application.World journal of methodology · 2026Review
- Bridging primary care with artificial intelligence: toward a global 1.5-Tier Healthcare System.npj health systems · 2026Review
- Leading Towards a Translation Readiness Framework: A Systematic Review of Deep Learning Approaches for Eye Disease Diagnosis.Diagnostics (Basel, Switzerland) · 2026Review
- Teleophthalmology for Retinal Disease Screening and Referral in Low- and Middle-Income Countries: A Case Overview of India.International ophthalmology · 2026Review
- Artificial intelligence-driven diabetic retinopathy research: mapping the evolution, coupling, and global collaboration landscape (1996-2026).Frontiers in endocrinology · 2026Review
- Nailfold capillaroscopy in diabetic retinopathy: microvascular insights, clinical value, and translational challenges - a narrative review.Frontiers in endocrinology · 2026Review
- ORDER-DR: external validation of severity grading and referable-risk stratification from fundus images.Frontiers in endocrinology · 2026Article
- Real-world validation of an AI-based non-mydriatic fundus camera in the diagnosis of diabetic retinopathy in Liberia.Frontiers in digital health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Artificial intelligence (AI) algorithms offer an effective solution to alleviate the burden of diabetic retinopathy (DR) screening in public health settings. However, there are challenges in translating diagnostic performance and its application when deployed in real-world conditions. Objective: This study aimed to assess the technical feasibility of integration and diagnostic performance of validated DR screening (DRS) AI algorithms in real-world outpatient public health settings. Methods: Prior to integrating an AI algorithm for DR screening, the study involved several steps: (1) Five AI companies, including four from India and one international company, were invited to evaluate their diagnostic performance using low-cost nonmydriatic fundus cameras in public health settings; (2) The AI algorithms were prospectively validated on fundus images from 250 people with diabetes mellitus, captured by a trained optometrist in public health settings in Chandigarh Tricity in North India. The performance evaluation used diagnostic metrics, including sensitivity, specificity, and accuracy, compared to human grader assessments; (3) The AI algorithm with better diagnostic performance was integrated into a low-cost screening camera deployed at a community health center (CHC) in the Moga district of Punjab, India. For AI algorithm analysis, a trained health system optometrist captured nonmydriatic images of 343 patients. Results: Three web-based AI screening companies agreed to participate, while one declined and one chose to withdraw due to low specificity identified during the interim analysis. The three AI algorithms demonstrated variable diagnostic performance, with sensitivity (60%-80%) and specificity (14%-96%). Upon integration, the better-performing algorithm AI-3 (sensitivity: 68%, specificity: 96, and accuracy: 88·43%) demonstrated high sensitivity of image gradability (99.5%), DR detection (99.6%), and referral DR (79%) at the CHC. Conclusions: This study highlights the importance of systematic AI validation for responsible clinical integration, demonstrating the potential of DRS to improve health care access in resource-limited public health settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.